2Ducharme M P, Edwards D J, McNamara P J, et al. Bioavailability of syrup andtablet formulalions of cefetamet pivoxil [J]. Antimicrob Agents Chemother,1993;37(12):2706
3Koup J R, Dubach U C, Blandt R, et al. Pharmacokinetics of cefetamet (Ro15-8074)and cefetamet pivoxil (Ro15-8075) after intravenous and oral doses in human [J].Antimicrob Agents Chemother,1988;32(4):573
4Blouin R A, Kneer J, Ambros R J, et al. Influence of antacid and ranitidine on thepharmacokineties of oral cefetamet pivoxil [J]. Antimicrob AgentsChemother,1990;34(9):1744
5Lode H, Fassbender M, Schaberg T, et al. Comparative pharmacokinetics of the neworal cephalosporins [J]. Drugs,1994;47(Suppl 3):10
6Hayton W L, Walstad R A, Thurmann-Nielsen E, et al. Pharmacokinetics ofintravenous cefetamet and oral cefetamet pivoxil in children [J]. Antimicrob AgentsChe-mother,1991;35(4):720
7Hayton W L, Kneer J, de Groot R, et al. Influence of maturation and growth oncefetamet pivoxil pharmacokinetics: rational dosing for infants [J]. Antimicrob AgentsChemother,1996;40(3):567
8Fassbender M, Lode H, Schaberg T, et al. Pharmacokinetics of new oralcephalosporins, including a new carbacephem [J]. Clin Infect Dis,1993;16(5):646
9Blouin R A, Kneer J, Stoeckel K, et al. Pharmacokinetics of intravenous cefetamet(Ro15-8074)and oral cefetamet pivoxil (Ro15-8075) in young and elderly subjects [J].Antimicrob Agents Chemother,1989;33(3):291
10Hayton W L, Kneer J, Blouin R A, et al. Pharmacokineties of intravenous cefetametand oral cefetamet pivoxil in patients with hepatic cirrosis [J]. Antimicrob AgentsChemother,1990;34(7):1318
